By combining all of the findings from the many investigations discussed above, a positive role of the MedDiet on obesity and inflammation seems quite clear
In a model of Type 1 diabetic nephropathy, Kawasaki et al explored the antifibrotic properties of linagliptin and discovered that, after 4 weeks, it decreased diabetic kidney fibrosis, which was associated with the repair of microRNA29s and the suppression of EndMT
Getting a screening mammogram can save your life, so dont delay
A well-functioning energy metabolism is important for energy production, which in turn is of great importance for maintaining basic functions in the body
And then, this is a common question, is when can I or can I even stop this medication eventually
What is our strategy to expand indications (e.g., obesity, MASH, CKD) ahead of the competition